{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:17:14Z","timestamp":1791497834376,"version":"4.3.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.mayocp.2021.01.030","type":"journal-article","created":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T02:39:55Z","timestamp":1625279995000},"page":"2407-2417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["The Effectiveness and Safety of Platelet-Rich Plasma for Chronic Wounds"],"prefix":"10.1016","volume":"96","author":[{"given":"Wenchun","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9368-6149","authenticated-orcid":false,"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison S.","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9123-0922","authenticated-orcid":false,"given":"Meritxell","family":"Urtecho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustapha","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahrish","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashar","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Abd-Rabu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3125-5351","authenticated-orcid":false,"given":"Zack","family":"Ashmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Kubrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry J.","family":"Prokop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5502-5975","authenticated-orcid":false,"given":"Mohammad Hassan","family":"Murad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mayocp.2021.01.030_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jval.2017.07.007","article-title":"An economic evaluation of the impact, cost, and medicare policy implications of chronic nonhealing wounds","volume":"21","author":"Nussbaum","year":"2018","journal-title":"Value Health"},{"issue":"3","key":"10.1016\/j.mayocp.2021.01.030_bib2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s12325-017-0478-y","article-title":"Chronic wound healing: a review of current management and treatments","volume":"34","author":"Han","year":"2017","journal-title":"Adv Ther"},{"issue":"5","key":"10.1016\/j.mayocp.2021.01.030_bib3","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.1524-475X.1999.00335.x","article-title":"Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies","volume":"7","author":"Smiell","year":"1999","journal-title":"Wound Repair Regen"},{"issue":"4","key":"10.1016\/j.mayocp.2021.01.030_bib4","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1177\/0363546511401576","article-title":"Platelet activation by collagen provides sustained release of anabolic cytokines","volume":"39","author":"Harrison","year":"2011","journal-title":"Am J Sports Med"},{"issue":"4","key":"10.1016\/j.mayocp.2021.01.030_bib5","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/trf.13998","article-title":"Standardizing the freeze-thaw preparation of growth factors from platelet lysate","volume":"57","author":"Strandberg","year":"2017","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.mayocp.2021.01.030_bib6","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.joms.2004.12.007","article-title":"Activation of platelet-rich plasma using thrombin receptor agonist peptide","volume":"63","author":"Landesberg","year":"2005","journal-title":"J\u00a0Oral Maxillofac Surg"},{"issue":"1","key":"10.1016\/j.mayocp.2021.01.030_bib7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1471-2180-13-47","article-title":"Antimicrobial activity of pure platelet-rich plasma against microorganisms isolated from oral cavity","volume":"13","author":"Drago","year":"2013","journal-title":"BMC Microbiol"},{"issue":"1","key":"10.1016\/j.mayocp.2021.01.030_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.transci.2009.05.006","article-title":"Autologous platelets and leukocytes can improve healing of infected high-energy soft tissue injury","volume":"41","author":"Cieslik-Bielecka","year":"2009","journal-title":"Transfus Apher Sci"},{"issue":"2","key":"10.1016\/j.mayocp.2021.01.030_bib9","first-page":"27","article-title":"Best practice guidelines: Wound management in diabetic foot ulcers","volume":"5","author":"Chadwick","year":"2014","journal-title":"Wounds Int"},{"issue":"1","key":"10.1016\/j.mayocp.2021.01.030_bib10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/wrr.12391","article-title":"WHS guidelines update: diabetic foot ulcer treatment guidelines","volume":"24","author":"Lavery","year":"2016","journal-title":"Wound Repair Regen"},{"issue":"1","key":"10.1016\/j.mayocp.2021.01.030_bib12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/wrr.12396","article-title":"Wound Healing Society 2015 update on guidelines for pressure ulcers","volume":"24","author":"Gould","year":"2016","journal-title":"Wound Repair Regen"},{"issue":"suppl 2","key":"10.1016\/j.mayocp.2021.01.030_bib14","doi-asserted-by":"crossref","first-page":"46S","DOI":"10.1016\/j.jvs.2015.10.007","article-title":"A\u00a0systematic review and meta-analysis of adjunctive therapies in diabetic foot ulcers","volume":"63","author":"Elraiyah","year":"2016","journal-title":"J\u00a0Vasc Sug"},{"issue":"11","key":"10.1016\/j.mayocp.2021.01.030_bib15","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S2213-8587(18)30240-7","article-title":"LeucoPatch system for the management of hard-to-heal diabetic foot ulcers in the UK, Denmark, and Sweden: an observer-masked, randomised controlled trial","volume":"6","author":"Game","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"10.1016\/j.mayocp.2021.01.030_bib16","first-page":"13796","article-title":"Autologous platelet-rich gel for lower-extremity ischemic ulcers in patients with type 2 diabetes","volume":"10","author":"Yang","year":"2017","journal-title":"Int J Clin Exp Med"},{"issue":"6","key":"10.1016\/j.mayocp.2021.01.030_bib17","first-page":"68","article-title":"A\u00a0prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers","volume":"52","author":"Driver","year":"2006","journal-title":"Ostomy Wound Manage"},{"issue":"suppl 6","key":"10.1016\/j.mayocp.2021.01.030_bib18","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.12968\/jowc.2018.27.Sup6.S20","article-title":"Autologous platelet-rich plasma in the treatment of venous leg ulcers in primary care: a randomised controlled, pilot study","volume":"27","author":"Burgos-Alonso","year":"2018","journal-title":"J\u00a0Wound Care"},{"issue":"3","key":"10.1016\/j.mayocp.2021.01.030_bib19","first-page":"129","article-title":"Skin grafting and topical application of platelet gel in the treatment of vascular lower extremity ulcers","volume":"15","author":"Serra","year":"2014","journal-title":"Acta Phlebologica"},{"key":"10.1016\/j.mayocp.2021.01.030_bib20","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.mayocp.2021.01.030_bib21","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.mayocp.2021.01.030_bib22","author":"Wells"},{"key":"10.1016\/j.mayocp.2021.01.030_bib23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12874-015-0091-1","article-title":"Hartung-Knapp-Sidik-Jonkman approach and its modification for random-effects meta-analysis with few studies","volume":"15","author":"Rover","year":"2015","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.mayocp.2021.01.030_bib24","series-title":"US Department of Health and Human Services. Agency for Healthcare Research and Quality, ed. Methods Guide for Effectiveness and Comparative Effectiveness Reviews","year":"2014"},{"issue":"4","key":"10.1016\/j.mayocp.2021.01.030_bib25","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/wrr.12294","article-title":"Autologous platelet-rich gel for treatment of diabetic chronic refractory cutaneous ulcers: a prospective, randomized clinical trial","volume":"23","author":"Li","year":"2015","journal-title":"Wound Repair Regen"},{"issue":"9","key":"10.1016\/j.mayocp.2021.01.030_bib26","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/01.ASW.0000577140.19174.9e","article-title":"Aurix gel is an effective intervention for chronic diabetic foot ulcers: a pragmatic randomized controlled trial","volume":"32","author":"Gude","year":"2019","journal-title":"Adv Skin Wound Care"},{"key":"10.1016\/j.mayocp.2021.01.030_bib27","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.avsg.2016.04.023","article-title":"Platelet-rich plasma for the treatment of clean diabetic foot ulcers","volume":"38","author":"Ahmed","year":"2017","journal-title":"Ann Vasc Surg"},{"issue":"3","key":"10.1016\/j.mayocp.2021.01.030_bib28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1742-481X.2011.00797.x","article-title":"Platelet-rich plasma versus platelet-poor plasma in the management of chronic diabetic foot ulcers: a comparative study","volume":"8","author":"Saad Setta","year":"2011","journal-title":"Int Wound J"},{"issue":"6","key":"10.1016\/j.mayocp.2021.01.030_bib29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0939-4753(04)80029-2","article-title":"A\u00a0controlled study of the use of autologous platelet gel for the treatment of diabetic foot ulcers","volume":"14","author":"Saldalamacchia","year":"2004","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"3","key":"10.1016\/j.mayocp.2021.01.030_bib30","doi-asserted-by":"crossref","first-page":"e30314","DOI":"10.17795\/nmsjournal30314","article-title":"The effect of platelet rich plasma dressing on healing diabetic foot ulcers","volume":"5","author":"Karimi","year":"2016","journal-title":"Nurs Midwifery Stud"},{"issue":"6","key":"10.1016\/j.mayocp.2021.01.030_bib31","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jdiacomp.2007.03.006","article-title":"Synergistic action of protease-modulating matrix and autologous growth factors in healing of diabetic foot ulcers. A prospective randomized trial","volume":"21","author":"Kakagia","year":"2007","journal-title":"J\u00a0Diabetes Complications"},{"issue":"9","key":"10.1016\/j.mayocp.2021.01.030_bib32","doi-asserted-by":"crossref","first-page":"550","DOI":"10.12968\/jowc.2018.27.9.550","article-title":"Role of platelet-rich plasma in healing diabetic foot ulcers: a prospective study","volume":"27","author":"Singh","year":"2018","journal-title":"J\u00a0Wound Care"},{"issue":"4","key":"10.1016\/j.mayocp.2021.01.030_bib33","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1007\/s00268-019-05316-0","article-title":"Randomized controlled trial on autologous platelet-rich plasma versus saline dressing in treatment of non-healing diabetic foot ulcers","volume":"44","author":"Elsaid","year":"2020","journal-title":"World J Surg"},{"key":"10.1016\/j.mayocp.2021.01.030_bib34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jss.2019.09.069","article-title":"Autologous platelet-rich gel for the treatment of diabetic sinus tract wounds: a clinical study","volume":"247","author":"Xie","year":"2020","journal-title":"J\u00a0Surg Res"},{"issue":"6","key":"10.1016\/j.mayocp.2021.01.030_bib35","doi-asserted-by":"crossref","first-page":"601","DOI":"10.5114\/pdia.2016.62415","article-title":"Role of plasma growth factor in the healing of chronic ulcers of the lower legs and foot due to ischaemia in diabetic patients","volume":"34","author":"Milek","year":"2017","journal-title":"Postepy Dermatol Alergol"},{"issue":"2","key":"10.1016\/j.mayocp.2021.01.030_bib36","first-page":"2258","article-title":"The study of the effectiveness of the drug combination of collagen and platelet-rich plasma for the regional treatment of venous ulcers","volume":"8","author":"Glukhov","year":"2017","journal-title":"Res J Pharm Biol Chem Sci"},{"issue":"6","key":"10.1016\/j.mayocp.2021.01.030_bib37","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0741-5214(03)00908-X","article-title":"Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcers","volume":"38","author":"Senet","year":"2003","journal-title":"J\u00a0Vasc Surg"},{"issue":"2","key":"10.1016\/j.mayocp.2021.01.030_bib38","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jtv.2016.11.003","article-title":"Efficacy and safety of the use of platelet-rich plasma to manage venous ulcers","volume":"26","author":"Escamilla Cardenosa","year":"2017","journal-title":"J\u00a0Tissue Viability"},{"key":"10.1016\/j.mayocp.2021.01.030_bib39","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/5584_2019_388","article-title":"Autologous platelet-rich plasma reduces healing time of chronic venous leg ulcers: a prospective observational study","volume":"1176","author":"Milek","year":"2019","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"10.1016\/j.mayocp.2021.01.030_bib40","first-page":"593","article-title":"Autologous platelet-rich plasma for treatment of venous leg ulcers: a prospective controlled study","volume":"32","author":"Etugov","year":"2018","journal-title":"J\u00a0Biol Regul Homeost Agents"},{"issue":"4","key":"10.1016\/j.mayocp.2021.01.030_bib41","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/iwj.13361","article-title":"Autologous platelet-rich plasma injection enhances healing of chronic venous leg ulcer: a prospective randomised study","volume":"17","author":"Elbarbary","year":"2020","journal-title":"Int Wound J"},{"issue":"1","key":"10.1016\/j.mayocp.2021.01.030_bib42","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4103\/idoj.IDOJ_119_19","article-title":"Comparison of efficacy of autologous platelet-rich fibrin versus unna's paste dressing in chronic venous leg ulcers: a comparative study","volume":"11","author":"Yuvasri","year":"2020","journal-title":"Indian Dermatol"},{"issue":"3","key":"10.1016\/j.mayocp.2021.01.030_bib43","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/jocd.12401","article-title":"Autologous platelet-rich plasma versus conventional therapy for the treatment of chronic venous leg ulcers: a comparative study","volume":"17","author":"Moneib","year":"2018","journal-title":"J\u00a0Cosmet Dermatol"},{"issue":"3","key":"10.1016\/j.mayocp.2021.01.030_bib44","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/iwj.13344","article-title":"Comparison of platelet-rich plasma gel in the care of the pressure ulcers with the dressing with serum physiology in terms of healing process and dressing costs","volume":"17","author":"Ucar","year":"2020","journal-title":"Int Wound J"},{"issue":"11","key":"10.1016\/j.mayocp.2021.01.030_bib45","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/sc.2014.144","article-title":"Role of local application of autologous platelet-rich plasma in the management of pressure ulcers in spinal cord injury patients","volume":"52","author":"Singh","year":"2014","journal-title":"Spinal Cord"},{"issue":"5","key":"10.1016\/j.mayocp.2021.01.030_bib47","doi-asserted-by":"crossref","first-page":"692","DOI":"10.2337\/diacare.22.5.692","article-title":"Healing of diabetic neuropathic foot ulcers receiving standard treatment. A meta-analysis","volume":"22","author":"Margolis","year":"1999","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.mayocp.2021.01.030_bib48","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/dme.13537","article-title":"Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study","volume":"35","author":"Ndosi","year":"2018","journal-title":"Diabet Med"},{"issue":"6","key":"10.1016\/j.mayocp.2021.01.030_bib49","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2337\/diacare.26.6.1879","article-title":"Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial","volume":"26","author":"Sheehan","year":"2003","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2021.01.030_bib50","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/dmrr.2240","article-title":"Priorities in offloading the diabetic foot","volume":"28","author":"Bus","year":"2012","journal-title":"Diabetes Metab Res Rev"},{"issue":"8","key":"10.1016\/j.mayocp.2021.01.030_bib51","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1080\/09638280010005585","article-title":"Quality of life in patients with diabetic foot ulcers","volume":"23","author":"Meijer","year":"2001","journal-title":"Disability Rehab"},{"issue":"11","key":"10.1016\/j.mayocp.2021.01.030_bib52","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/01.PHM.0000140800.83146.FA","article-title":"Assessing persistent pain and its relation to affective distress, depressive symptoms, and pain catastrophizing in patients with chronic wounds: a pilot study","volume":"83","author":"Roth","year":"2004","journal-title":"Am J Phys Med Rehabil"},{"issue":"7","key":"10.1016\/j.mayocp.2021.01.030_bib53","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/00007632-200104010-00012","article-title":"Centralization phenomenon as a prognostic factor for chronic low back pain and disability","volume":"26","author":"Werneke","year":"2001","journal-title":"Spine (Phila Pa 1976"},{"issue":"6","key":"10.1016\/j.mayocp.2021.01.030_bib54","doi-asserted-by":"crossref","first-page":"440","DOI":"10.2340\/0001555573440443","article-title":"Quality of life in chronic leg ulcer patients. An assessment according to the Nottingham Health Profile","volume":"73","author":"Lindholm","year":"1993","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.mayocp.2021.01.030_bib55","first-page":"290","article-title":"The prevalence and occurrence of diabetic foot ulcer pain and its impact on health-related quality of life","volume":"7","author":"Ribu","year":"2006","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.mayocp.2021.01.030_bib56","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.maturitas.2018.08.013","article-title":"Pain management of chronic wounds: Diabetic ulcers and beyond","volume":"117","author":"Paschou","year":"2018","journal-title":"Maturitas"},{"issue":"13","key":"10.1016\/j.mayocp.2021.01.030_bib57","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJMra1507771","article-title":"Opioid abuse in chronic pain\u2014misconceptions and mitigation strategies","volume":"374","author":"Volkow","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.mayocp.2021.01.030_bib58","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.imbio.2011.01.001","article-title":"Macrophages in skin injury and repair","volume":"216","author":"Mahdavian Delavary","year":"2011","journal-title":"Immunobiology"},{"issue":"5","key":"10.1016\/j.mayocp.2021.01.030_bib59","doi-asserted-by":"crossref","first-page":"222","DOI":"10.12968\/jowc.1997.6.5.222","article-title":"Pain in venous leg ulcers","volume":"6","author":"Hofman","year":"1997","journal-title":"J\u00a0Wound Care"},{"issue":"171","key":"10.1016\/j.mayocp.2021.01.030_bib60","first-page":"2","article-title":"Pain assessment in patients with venous leg ulcer treated by compression therapy with unnas boot","volume":"7","author":"Vilela","year":"2016","journal-title":"J\u00a0Tissue Sci Eng"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561962100166X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561962100166X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:36:30Z","timestamp":1758418590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002561962100166X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":57,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S002561962100166X"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2021.01.030","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Effectiveness and Safety of Platelet-Rich Plasma for Chronic Wounds","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2021.01.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}